Celerion Inc. Sustainability Profile
Celerion Inc., a leading provider of clinical research services, is headquartered in the United States and operates across major regions including North America and Europe. Founded in 1979, Celerion has established itself in the biopharmaceutical industry, specialising in early clinical research and drug development services. The company offers a range of unique services, including bioanalytical testing, clinical pharmacology, and patient recruitment, which are designed to accelerate the drug development process. Celerion's commitment to innovation and quality has positioned it as a trusted partner for pharmaceutical and biotechnology companies worldwide. With a strong track record of successful studies and a focus on regulatory compliance, Celerion continues to play a pivotal role in advancing healthcare solutions.
DitchCarbon Score
How does Celerion Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Celerion Inc.'s score of 28 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Celerion Inc.'s reported carbon emissions
Celerion Inc., headquartered in the United States, has made significant commitments towards reducing its carbon emissions and addressing climate change. Although specific emissions data is currently unavailable, the company has pledged to ambitious emissions reduction targets in alignment with the Science Based Targets initiative (SBTi). Celerion aims to achieve net-zero emissions across all scopes by 2050, with a commitment initiated in 2023. The company's long-term climate strategy focuses on limiting global temperature rise to 1.5°C, reflecting its dedication to sustainable practices within the pharmaceuticals, biotechnology, and life sciences sector. Celerion's commitment to net-zero emissions underscores its proactive approach to environmental responsibility, although detailed emissions figures and specific reduction targets are yet to be disclosed.
How Carbon Intensive is Celerion Inc.'s Industry?
How Carbon Intensive is Celerion Inc.'s Location?
Celerion Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Celerion Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
